Dr. Schiffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4100 John R St
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8767- Is this information wrong?
Education & Training
- NYU Grossman School of MedicineResidency, Internal Medicine, 1968 - 1972
- New York University School of MedicineClass of 1968
Certifications & Licensure
- MI State Medical License 1997 - 2025
- MD State Medical License 1975 - 1997
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2010
- Join now to see all
Clinical Trials
- Trial to Reduce Alloimmunization to Platelets (TRAP) Start of enrollment: 1989 Aug 01
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome Start of enrollment: 2001 Aug 01
- Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 2003 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Project Confirm: Accelerated Drug Approvals for CML-Response.Norsworthy, K. J., Norsworthy, K. J., Norsworthy, K. J., Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Ch...> ;Clinical Cancer Research. 2024 Jan 5
- Glasdigib fails to slay the hedgehog in pivotal AML trials.Charles A Schiffer> ;Leukemia. 2023 Dec 1
- New patterns of genetic instability in chronic myeloid leukemia: interesting, but not ready for clinical use.Charles A Schiffer> ;Haematologica. 2023 Sep 1
- Join now to see all
Journal Articles
- Promoting Apoptosis with Venetoclax — A Benefit for Older Patients with AMLCharles Schiffer, MD, The New England Journal of Medicine
Abstracts/Posters
- Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...Charles A. Schiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid LeukemiaCharles A. Schiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- High Dependence on Medicare and Foundation Grant Assistance Among Patients with Hematologic Malignancies Receiving Novel Oral TherapeuticsCharles A. Schiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Other
- To What Extent Can Mathematical Modeling Inform the Design of Clinical Trials? The Example of Safe Dose Reduction of Tyrosine Kinase Inhibitors in Responding Patients ...Charles Schiffer, MD, Haematologica
https://www.doximity.com/articles/4681238f-f736-4d40-8426-f4cf919fa658
UpToDate, Wolters Kluwer Health - 2012-02-14 - To What Extent Can Mathematical Modeling Inform the Design of Clinical Trials? The Example of Safe Dose Reduction of Tyrosine Kinase Inhibitors in Responding Patients ...Charles Schiffer, MD, Haematologica
https://www.doximity.com/articles/4681238f-f736-4d40-8426-f4cf919fa658
UpToDate, Wolters Kluwer Health - 2013-03-20 - To What Extent Can Mathematical Modeling Inform the Design of Clinical Trials? The Example of Safe Dose Reduction of Tyrosine Kinase Inhibitors in Responding Patients ...Charles Schiffer, MD, Haematologica
https://www.doximity.com/articles/4681238f-f736-4d40-8426-f4cf919fa658
UpToDate, Wolters Kluwer Health - 2013-01-03 - Join now to see all
Authored Content
- Promoting Apoptosis with Venetoclax — A Benefit for Older Patients with AMLAugust 2020
Press Mentions
- Combo Protocol Promising for Older AML PatientsAugust 13th, 2020
Grant Support
- Transfusion Trial To Prevent Platelet AlloimmunizationNational Heart, Lung, And Blood Institute1994–1995
- Mechanisms Of Drug Resistance In Acute Myeloid LeukemiaNational Cancer Institute1990–1994
- Transfusion Trial To Prevent Platelet AllolimmunizationNational Heart, Lung, And Blood Institute1989–1993
- Mechanisms Of Platelet RefractorinessNational Heart, Lung, And Blood Institute1986–1988
Professional Memberships
- Fellow
Hospital Affiliations
- DMC Detroit Receiving Hospital & University Health CenterDetroit, Michigan
- DMC Harper University HospitalDetroit, Michigan
- Karmanos Cancer CenterDetroit, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: